Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study

This study has been completed.

Sponsored by:	Bispebjerg Hospital
Information provided by:	Bispebjerg Hospital
ClinicalTrials.gov Identifier:	NCT00206895

Purpose

The purpose of the study is to evaluated the efficacy and tolerability of methyl aminolevulinate and 5-aminolevulinic acid photodynamic therapy in patients with moderate to severe facial acne vulgaris in a randomized controlled and investigator blinded trial.

Condition	Intervention
Acne Vulgaris	Procedure: Photodynamic therapy

MedlinePlus related topics: Acne

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Further study details as provided by Bispebjerg Hospital:

Primary Outcome Measures:

Lesion counts (non-inflammatory and inflammatory)
Leeds Revised Acne Grading System

Secondary Outcome Measures:

Pain
Side effects

Estimated Enrollment:	24
Study Start Date:	November 2004

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:18 years or older, good health, more than 12 inflammatory facial acne lesions -

Exclusion Criteria:skin type VI, pregnant or lactating woman. Oral retinoid use within one year, systemic antibiotics within 1 month, topical acne treatment within 2 weeks.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00206895

Locations

Denmark, Copenhagen NV
Bispebjerg Hospital
Copenhagen, Copenhagen NV, Denmark, 2400

Sponsors and Collaborators

Bispebjerg Hospital

Investigators

Study Director:

Hans Christian Wulf, MD, Sci

Bispebjerg Hospital

More Information

Study ID Numbers:	KF-01-177/04
Study First Received:	September 12, 2005
Last Updated:	October 10, 2006
ClinicalTrials.gov Identifier:	NCT00206895
Health Authority:	Denmark: The Ministry of the Interior and Health

Study placed in the following topic categories:

Exanthema
Facial Dermatoses
Facies

Skin Diseases
Sebaceous Gland Diseases
Acne Vulgaris

Additional relevant MeSH terms:

Acneiform Eruptions

ClinicalTrials.gov processed this record on January 16, 2009